Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Neovasc Inc. T.NVC


Primary Symbol: NVCN

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.


NDAQ:NVCN - Post by User

Comment by Makstockson Aug 06, 2018 12:15pm
117 Views
Post# 28417864

RE:RE:I'm not complaining

RE:RE:I'm not complaining
Looking like we lost it at 4.3 cents -- its a shame really. ~ 25% total number of deaths happen due to a form of heart disease or malfunction in the USA. You would think that the products that NVCN manufactures would be selling like hot cakes. Heart Disease on average is really high up on the charts for overall killer around the world...Do you think its the executives that practiced heart surgery holding the market back? Or is it companies like Boston Scientific just running the show?

I realize companies fall into death spiral financing. Some cases seem corrupt. Others just the nature of the beast.
HMNY failed because its business model was structured the same as Netflix. Subscription based profits, basically when companies start out with these business principles they accept the fact they will lose a lot of money. Until subscription counts are high enough. Netflix struggles enough, I dont think people are that interested in getting deals on expensive movie dates/trip nights.
NFLX produces their own tv series and theyre awesome. HMNY was compared to NFLX at one point and I always thought MoviePass was a horrible rendition.
NVCN helps people live a better quality of life. Maybe even save it.
Apples to oranges. My rant references back to your post earlier last week.
<< Previous
Bullboard Posts
Next >>